Recent developments in preventing recurrent preterm birth.
Spong
Catherine Y
CY
D019326:17-alpha-Hydroxyprogesterone / Q000627:therapeutic use*; D005260:Female; D040361:Healthy People Programs; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011374:Progesterone / Q000627:therapeutic use*; D012307:Risk Factors
D011374:Progesterone; D019326:17-alpha-Hydroxyprogesterone